[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Placenta Growth Factor Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2020 | 107 pages | ID: P64BED767A76EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Placenta Growth Factor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Placenta Growth Factor market segmented into
  • Aflibercept
  • Aflibercept Biosimilar
  • SL-186
  • SL-188
  • Others
Based on the end-use, the global Placenta Growth Factor market classified into
  • Branch Retinal Vein Occlusion
  • Myopia
  • Neovascular Glaucoma
  • Others
Based on geography, the global Placenta Growth Factor market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Alteogen Inc.
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd
  • Clearside BioMedical, Inc.
  • Formycon AG
  • Regeneron Pharmaceuticals Inc
  • ThromboGenics NV
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL PLACENTA GROWTH FACTOR INDUSTRY

2.1 Summary about Placenta Growth Factor Industry
2.2 Placenta Growth Factor Market Trends
  2.2.1 Placenta Growth Factor Production & Consumption Trends
  2.2.2 Placenta Growth Factor Demand Structure Trends
2.3 Placenta Growth Factor Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Aflibercept
  4.2.2 Aflibercept Biosimilar
  4.2.3 SL-186
  4.2.4 SL-188
  4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Branch Retinal Vein Occlusion
  4.3.2 Myopia
  4.3.3 Neovascular Glaucoma
  4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Aflibercept
  5.2.2 Aflibercept Biosimilar
  5.2.3 SL-186
  5.2.4 SL-188
  5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Branch Retinal Vein Occlusion
  5.3.2 Myopia
  5.3.3 Neovascular Glaucoma
  5.3.4 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Aflibercept
  6.2.2 Aflibercept Biosimilar
  6.2.3 SL-186
  6.2.4 SL-188
  6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Branch Retinal Vein Occlusion
  6.3.2 Myopia
  6.3.3 Neovascular Glaucoma
  6.3.4 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Aflibercept
  7.2.2 Aflibercept Biosimilar
  7.2.3 SL-186
  7.2.4 SL-188
  7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Branch Retinal Vein Occlusion
  7.3.2 Myopia
  7.3.3 Neovascular Glaucoma
  7.3.4 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Aflibercept
  8.2.2 Aflibercept Biosimilar
  8.2.3 SL-186
  8.2.4 SL-188
  8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Branch Retinal Vein Occlusion
  8.3.2 Myopia
  8.3.3 Neovascular Glaucoma
  8.3.4 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Aflibercept
  9.2.2 Aflibercept Biosimilar
  9.2.3 SL-186
  9.2.4 SL-188
  9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Branch Retinal Vein Occlusion
  9.3.2 Myopia
  9.3.3 Neovascular Glaucoma
  9.3.4 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Alteogen Inc.
  10.1.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  10.1.3 Clearside BioMedical, Inc.
  10.1.4 Formycon AG
  10.1.5 Regeneron Pharmaceuticals Inc
  10.1.6 ThromboGenics NV
10.2 Placenta Growth Factor Sales Date of Major Players (2017-2020e)
  10.2.1 Alteogen Inc.
  10.2.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  10.2.3 Clearside BioMedical, Inc.
  10.2.4 Formycon AG
  10.2.5 Regeneron Pharmaceuticals Inc
  10.2.6 ThromboGenics NV
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Placenta Growth Factor Product Type Overview
Table Placenta Growth Factor Product Type Market Share List
Table Placenta Growth Factor Product Type of Major Players
Table Brief Introduction of Alteogen Inc.
Table Brief Introduction of Chengdu Kanghong Pharmaceuticals Group Co Ltd
Table Brief Introduction of Clearside BioMedical, Inc.
Table Brief Introduction of Formycon AG
Table Brief Introduction of Regeneron Pharmaceuticals Inc
Table Brief Introduction of ThromboGenics NV
Table Products & Services of Alteogen Inc.
Table Products & Services of Chengdu Kanghong Pharmaceuticals Group Co Ltd
Table Products & Services of Clearside BioMedical, Inc.
Table Products & Services of Formycon AG
Table Products & Services of Regeneron Pharmaceuticals Inc
Table Products & Services of ThromboGenics NV
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Placenta Growth Factor Market Forecast (Million USD) by Region 2021f-2026f
Table Global Placenta Growth Factor Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Placenta Growth Factor Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Placenta Growth Factor Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Placenta Growth Factor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Placenta Growth Factor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Placenta Growth Factor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Placenta Growth Factor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Placenta Growth Factor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Placenta Growth Factor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Placenta Growth Factor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aflibercept Biosimilar Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-186 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SL-188 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Branch Retinal Vein Occlusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Myopia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Neovascular Glaucoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Placenta Growth Factor Sales Revenue (Million USD) of Alteogen Inc. 2017-2020e
Figure Placenta Growth Factor Sales Revenue (Million USD) of Chengdu Kanghong Pharmaceuticals Group Co Ltd 2017-2020e
Figure Placenta Growth Factor Sales Revenue (Million USD) of Clearside BioMedical, Inc. 2017-2020e
Figure Placenta Growth Factor Sales Revenue (Million USD) of Formycon AG 2017-2020e
Figure Placenta Growth Factor Sales Revenue (Million USD) of Regeneron Pharmaceuticals Inc 2017-2020e
Figure Placenta Growth Factor Sales Revenue (Million USD) of ThromboGenics NV 2017-2020e


More Publications